Immunological self/nonself discrimination

Van Parijs L, Abbas AK: Homeostasis and self-tolerance in the immune system: turning lymphocytes off [Review] [50 refs]. Science 1998;280:243–248.

King C, Sarvetnick N: Organ-specific autoimmunity [Review] [75 refs]. Curr Opinion Immunol 1997; 9:863–871.

Del Prete G: The concept of type-1 and type-2 helper T cells and their cytokines in humans [Review] [120 refs]. Intern Rev Immunol 1998;16:427–455.

Romagnani S, Parronchi P, D’Elios MM, Romagnani P, Annunziato F, Piccinni MP, et al.: An update on human Thl and Th2 cells [Review] [30 refs]. Intern Arch Allergy Immunol 1997;] 13:153–156.

Adorini L, Trembleau S: Immune deviation towards Th2 inhibits Th-1-mediated autoimmune diabetes [Review] [58 refs]. Biochem Soc Trans 1997;25:625–629.

Shaw AS, Dustin ML: Making the T cell receptor go the distance: a topological view of T cell activation [Review] [58 refs]. Immunity 1997;6:361–369.

Marks MS: Protein sorting within the MHC class II antigen-processing pathway [Review] [124 refs]. Immunol Res 1998; 17: 141–154.

Whitton JL: An overview of antigen presentation and its central role in the immune response [Review] [24 refs]. Curr Top Microbiol Immunol 1998;232:1–13.

Engering A, Lefkovits I, Pieters J: Analysis of subcellular organelles involved in major histocompatibility complex (MHC) class II-restricted antigen presentation by electrophoresis [Review] [56 refs]. Electrophoresis 1997;18:2523–2530.

Grewal IS, Flavell RA: The role of CD40 ligand in costimulation and T-cell activation [Review] [100 refs]. Immunol Rev 1996; 153:85–106.

Grewal IS, Foellmer HG, Grewal KD, Xu J, Hardardottir F, Baron JL, et al.: Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 1996;273:1864–1867.

Guo Y, Wu Y, Shinde S, Sy MS, Aruffo A, Liu Y: Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. J Exp Med 1996; 184:955–961.

Shinde S, Wu Y, Guo Y, Niu Q, Xu J, Grewal IS, Flavell R, Liu Y: CD40L is important for induction of, but not response to, costimulatory activity. ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L. J Immunol 1996;157:2764–2768.

Yang Y, Wilson JM:CD401iganddependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 1996; 273:1862–1864.

Goldstein MD, Debenedette MA, Hollenbaugh D, Watts TH: Induction of costimulatory molecules B7-1 and B7-2 in murine B cells. the CBA/N mouse reveals a role for Bruton’s tyrosine kinase in CD40-mediated B7 induction. Mol Immunol 1996;33:541–552.

Mackey MF, Barth RJ Jr, Noelle RJ: The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells [Review] [105 refs]. J Leuk Biol 1998;63:418–428.

Lechler R, Marelli-Berg FM: Mechanisms of peripheral T-cell tolerance [Review] [33refs]. J Viral Hepatitis 1997;4 Suppl 2:1–5.

Lu P, Wang YL, Linsley PS: Regulation of self-tolerance by CD80/CD86 interactions [Review] [34 refs]. Curr Opinion Immunol 1997;9:858–862.

Schweitzer AN, Sharpe AH: The complexity of the B7-CD28/ CTLA-4 costimulatory pathway [Review] [48 refs]. Agents & Actions Suppl. 1998;49:33–43.

Tivol EA, Schweitzer AN, Sharpe AH: Costimulation and autoimmunity [Review] [66 refs]. Curr Opinion Immunol 1996;8:822–830.

Gill RG, Coulombe M, Lafferty KJ: Pancreatic islet allograft immunity and tolerance: the two-signal hypothesis revisited [Review] [94 refs]. Immunol Rev 1996;149:75–96.

Schultze J, Nadler LM, Gribben JG: B7-mediated costimulation and the immune response [Review] [107 refs]. Blood Reviews 1996; 10:111–127.

Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation [Review] [117 refs]. AnnuRev Immunol 1996; 14:233–258.

Kisielow P, Miazek A: Thymic selection and tolerance [Review] [34 refs]. Transplant Proc 1996; 28:3429–3430.

Teh HS, Motyka B, Teh SJ:Influence of the affinity of selecting ligands on T cell positive and negative selection and the functional maturity of the positively selected Tcells [Review] [52refs]. Crit Rev Immunol 1997;17:399–410.

Bevan MJ: In thymic selection, peptide diversity gives and takes away [Review] [16 refs]. Immunity 1997;7:175–178.

Fowlkes BJ, Schweighoffer E: Positive selection of T cells [Review] [54 refs]. Curr Opinion Immunol 1995;7:188–195.

Kalwy S, Marty MC, Bausero P, Pessac B: Myelin basic proteinrelated proteins in mouse brain and immune tissues. J Neurochem 1998;70:435–438.

Kuramoto H, Hozumi I, Inuzuka T, Sato S: Occurrence of myelinassociated glycoprotein (MAG)like immunoreactivity in some nervous, endocrine, and immunerelated cells of the rat. An immunohistochemical study. Mol Chem Neuropathol 1997;31:85–94.

Kojima K, Reindl M, Lassmann H, Wekerle H, Linington C: The thymus and self-tolerance: co-existence of encephalitogenic SI00 beta-specific T cells and their nominal autoantigen in the normal adult rat thymus. Intern Immunol 1997:9:897–904.

Pribyl TM, Campagnoni CW, Kampf K, Kashima T, Handley VW, McMahon J, et al.: Expression of the myelin proteolipid protein gene in the human fetal thymus. J Neuroimmunol 1996; 67:125–130.

Fritz RB, Kalvakolanu I: Thymic expression of the golli-myelin basic protein gene in the SJL/J mouse. J Neuroimmunol 1995;57: 93–99.

Pribyl TM, Campagnoni CW, Kampf K, Kashima T, Handley VW, McMahon J, et al.: The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in the immune and central nervous systems. Proc Natl Acad Sci USA 1993;90:10,695–10,699.

Mathisen PM, Pease S, Garvey J, Hood L, Readhead C: Identification of an embryonic isoform of myelin basic protein that is expressed widely in the mouse embryo. Proc Natl Acad Sci USA 1993;90:10,125–10,129.

Castro JE, Listman JA, Jacobson BA, Wang Y, Lopez PA, Ju S, et al.: Fas modulation of apoptosis during negative selection of thymocytes. Immunity 1996;5:617–627.

Noda S, Kosugi A, Saitoh S, Narumiya S, Hamaoka T: Protection from anti-TCR/CD3-induced apoptosis in immature thymocytes by a signal through thymic shared antigen-l/stem cell antigen-2. J Exp Med 1996;183: 2355–2360.

von Boehmer H:Thymic selection: a matter of life and death. Immunol Today 1992;13:454–458.

Janeway CA Jr:Thymic selection: two pathways to life and two to death [Review] [47 refs]. Immunity 1994;1:3–6.

Robey E, Fowlkes BJ: Selective events in T cell development [Review] [120 refs]. Annu Rev Immunol 1994; 12:675–705.

Wang R, Nelson A, Kimachi K, Grey HM, Farr AG: The role of peptides in thymic positive selection of class II major histocompatibility complex-restricted T cells. Proc Natl Acad Sci USA 1998; 95:3804–3809.

Ignatowicz L, Rees W, Pacholczyk R, Ignatowicz H, Kushnir E, Kappler J, et al.: T cells can be activated by peptides that are unrelated in sequence to their selecting peptide. Immunity 1997;7:179–186.

Surh CD, Lee DS, Fung-Leung WP, Karlsson L, Sprent J: Thymic selection by a single MHC/peptide ligand produces a semidiverse repertoire of CD4+ T cells. Immunity 1997;7:209–219.

Hu Q, Bazemore Walker CR, Girao C, Opferman JT, Sun J, Shabanowitz J, et al.: Specific recognition of thymic self-peptides induces the positive selection of cytotoxic T lymphocytes. Immunity 1997;7:221–231.

Hogquist KA, Tomlinson AJ, Kieper WC, McGargill MA, Hart MC, Naylor S, et al.: Identification of a naturally occurring ligand for thymic positive selection. Immunity 1997;6:389–399.

Barnden MJ, Heath WR, Rodda S, Carbone, FR: Peptide antagonists that promote positive selection are inefficient at T cell activation and thymocyte deletion. Eur J Immunol 1994;24:2452–2456.

Girao C, Hu Q, Sun J, AshtonRickardt PG: Limits to the differential avidity model of T cell selection in the thymus. J Immunol 1997;159:4205–4211.

Jameson SC, Hogquist KA, Bevan MJ: Positive selection of thymocytes. Annu Rev Immunol 1995; 13:93–126.

Hogquist KA, Bevan MJ: The nature of the peptide/MHC ligand involved in positive selection. Sem Immunol1996;8:63–68.

Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone, FR: T cell receptor antagonist peptides induce positive selection. Cell 1994;76:17–27.

Pawlowski TJ, Singleton MD, Loh DY, Berg R, Staerz UD: Permissive recognition duringpositive selection. Eur J Immunol 1996;26: 851–857.

Jameson SC, Hogquist KA, Bevan MJ: Specificity and flexibility in thymic selection. Nature 1994; 369:750–752.

Barnden MJ, Heath WR, Carbone FR: Down-modulation of CD8 beta-chain in response to an altered peptide ligand enables developing thymocytes to escape negative selection. Cell Immunol 1997;175:111–119.

Jameson SC, Bevan MJ: T-cell selection [In Process Citation]. Curr Opinion Immunol 1998;10: 214–219.

Lafferty KJ, Prowse SJ, Simeonovic CJ, Warren HS: Immunobiology of tissue transplantation: a return to the passenger leukocyte concept [Review] [116 refs]. Annu Rev Immunol 1983; 1:143–173.

Janeway CA Jr: The immune system evolved to discriminate infectious nonself from noninfectious self [Review] [38 refs]. Immunol Today 1992;13:11–16.

Janeway CA Jr, Goodnow CC, Medzhitov R: Danger pathogen on the premises: Immunological tolerance [Review] [20 refs]. Curr Biol 1996;6:519–522.

Medzhitov R, Janeway CAJr: Innate immunity: impact on the adaptive immune response [Review] [40 refs]. Curr Opinion Immunol 1997;9:4–9.

Medzhitov R, Janeway CA Jr: Innate immunity: the virtues of a nonclonal system of recognition [Review] [17 refs]. Cell 1997;91: 295–298.

Fenton RG, Longo DL: Danger vs tolerance: paradigms for future studies of tumor-specific cytotoxic T lymphocytes [editorial; comment] [Review] [28 refs]. J Natl Can Inst 1997;89:272–275.

Matzinger P: Tolerance, danger, and the extended family [Review] [157 refs]. Annu Rev Immunol 1994;12:991–1045.

Sousa CR, Hieny S, Scharton-Kersten T, Jankovic D, Charest H, Germain RN, et al.: In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas [see comments]. J Exp Med 1997;186:1819–1829.

Mannie MD: Immune discrimination of self and nonself: a unified theory for the induction of self tolerance among thymocytes and mature peripheral T cells. Med Hypotheses 1993;40:105–112.

Bretscher P, Cohn M: A theory of self-nonself discrimination. Science 1970;169:1042–1049.

Mueller DL, Jenkins MK, Schwartz RH: Clonal expansion vs functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989;7:445–480.

Purbhoo MA, Sewell AK, Klenerman P, Goulder PJ, Hilyard KL, Bell JI, et al.: Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade. Proc Natl Acad Sci USA 1998;95: 4527–4532.

Totsuka M, Furukawa S, Sato E, Ametani A, Kaminogawa S: Antigen-specific inhibition of CD4+ T-cell responses to beta-lactoglobulin by its single amino acidsubstituted mutant form through T-cell receptor antagonism. Cytotechnology 1997;25:115–126.

Viola A, Linkert S, Lanzavecchia A: A T cell receptor (TCR) antagonist competitively inhibits serial TCR triggering by low-affinity ligands, but does not affect triggering by high-affinity anti-CD3 antibodies. Eur J Immunol 1997; 27:3080–3083.

La Face DM, Couture C, Anderson K, Shih G, Alexander J, Sette A, et al.: Differential T cell signaling induced by antagonist peptide-MHC complexes and the associated phenotypic responses. J Immunol 1997; 158:2057–2064.

Liu C, Goldstein J, Graziano RF, He J, O’Shea JK, Deo Y, et al: F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes. J Clin Invest 1996:98: 2001–2007.

Kuchroo VK, Greer JM, Kaul D, Ishioka G, Franco A, Sette A, et al.: A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. J Immunol 1994;153:3326–3336.

Racioppi L, Ronchese F, Matis LA, Germain RN: Peptide-major histocompatibility complex class II complexes with mixed agonist/ antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J Exp Med 1993;177:1047–1060.

Snoke K, Alexander J, Franco A, Smith L, Brawley JV, Concannon P, et al.: The inhibition of different T cell lines specific for the same antigen with TCR antagonist peptides. J Immunol 1993; 151: 6815–6821.

Mannie MD, Rosser JM, White GA: Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition. J Immunol 1995;154:2642–2654.

Rogers PR, Grey HM, Croft M: Modulation of naive CD4 T cell activation with altered peptide ligands: the nature of the peptide and presentation in the context of costimulation are critical for a sustained response. J Immunol 1998; 160:3698–3704.

Daniel C, Grakoui A, Allen PM: Inhibition of an in vitro CD4+ T cell allo-response using altered peptide ligands. J Immunol 1998; 160:3244–3250.

Sloan-Lancaster J, Allen PM: Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol 1996; 14:1–27.

Hollsberg P, Weber WE, Dangond F, Batra V, Sette A, Hafler DA: Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand. Proc Natl Acad Sci USA 1995;92:4036–4040.

Madrenas J, Germain RN: Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation. Semin Immunol 1996; 8:83–101.

Madrenas J, Chau LA, Smith J, Bluestone JA, Germain RN: The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J Exp Med 1997;185:219–229.

Reis e Sousa C, Levine EH, Germain RN: Partial signaling by CD8+ T cells in response to antagonist ligands. J Exp Med 1996; 184:149–157.

Madrenas J, Wange RL, Wang JL, Isakov N, Samelson LE, Germain RN: Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists [see comments]. Science 1995;267:515–518.

Racioppi L, Germain RN: Modified T-cell receptor ligands: moving beyond a strict occupancy model for T-cell activation by antigen. Chem Immunol 1995;60: 79–99.

Evavold BD, Allen PM: Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 1991; 252:1308–1310.

Evavold BD, Sloan-Lancaster J, Hsu BL, Allen PM: Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J Immunol 1993; 150:3131–3140.

Germain RN: T-cell signaling: the importance of receptor clustering [Review] [29 refs]. Curr Biol 1997;7:R640–644.

Dustin ML, Bromley SK, Kan Z, Peterson DA, Unanue ER: Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc Natl Acad Sci USA 1997;94:3909–3913.

Washington EA, Kimpton WG, Holder JE, Cahill RN: Role of the thymus in the generation of skinhoming alpha beta and gamma delta virgin T cells. Eur J Immunol 1995;25:723–727.

Kurts C, Heath WR, Carbone FR, Allison J, Miller JF, Kosaka H: Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 1996; 184:923–930.

Forster I, Lieberam I: Peripheral tolerance of CD4 T cells following local activation in adolescent mice. Eur J Immunol 1996;26: 3194–3202.

Kimpton WG, Washington EA, Cahill RN: Virgin alpha beta and gamma delta T cells recirculate extensively through peripheral tissues and skin during normal development of the fetal immune system. Intern Immunol 1995;7: 1567–1577.

Kroemer G, Cuende E, Martinez C: Compartmentalization of the peripheral immune system. Adv Immunol 1993;53:157–216.

Mannie MD: The post-activation refractory phase: a mechanism to measure antigenic complexity and ensure self-tolerance among mature peripheral T lymphocytes. Med Hypotheses 1996;47:467–470.

Kaufman M, Andris F, Leo O: A model for antigen-induced T cell unresponsiveness based on autophosphorylative protein tyrosine kinase activity. Intern Immunol 1996;8:613–624.

Willems F, Andris F, Xu D, Abramowicz D, Wissing M, Goldman M, et al.: The induction of human T cell unresponsiveness by soluble anti-CD3 mAb requires T cell activation. Intern Immunol 1995;7:1593–1598.

Dubois PM, Andris F, Shapiro RA, Gilliland LK, Kaufman M, Urbain J, et al.: T cell long-term hyporesponsiveness follows antigen receptor engagement and results from defective signal transduction. Eur J Immunol 1994;24: 348–354.

Andris F, Van Mechelen M, De Mattia F, Baus E, Urbain J, Leo O: Induction of T cell unresponsiveness by anti-CD3 antibodies occurs independently of co-stimulatory functions. Eur J Immunol 1996;26:1187–1195.

Andris F, Van Mechelen M, Legrand N, Dubois PM, Kaufman M, Urbain J, et al.: Induction of long-term but reversible unresponsiveness after activation of murine T cell hybridomas. Intern Immunol 1991;3:609–616.

Pantaleo G, Olive D, Poggi A, Pozzan T, Moretta L, Moretta A: Antibody-induced modulation of the CD3/T cell receptor complex causes T cell refractoriness by inhibiting the early metabolic steps involved in T cell activation. J Exp Med1987; 166:619–624.

Cai Z, Kishimoto H, Brunmark A, Jackson MR, Peterson PA, Sprent J: Requirements for peptideinduced T cell receptor downregulation on naive CD8+ T cells. J Exp Med 1997;185:641–651.

Mannie MD, White GA, Lake KR, Nardella JP, Marinakis CA, McConnell TJ: T-helper lymphocytes specific for myelin basic protein: low-density activation prolongs a postactivation refractory phase marked by decreased pathogenicity and enhanced sensitivity to anergy. Cell Immunol 1996;172:108–117.

Kramer S, Schimpl A, Hunig T: Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J Exp Med 1995; 182:1769–1776.

Simpson SJ, Mizoguchi E, Allen D, Bhan AK, Terhorst C: Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis. Eur J Immunol 1995;25:2618–2625.

Heuer J, Kolsch E: Functional studies on the role of I-A molecules expressed by the antigen-specific T suppressor cell clone HF1. J Immunol 1985;134:4031–4034.

Reske-Kunz AB, Reske K, Rude E: Cloned murine Ia+ BK-BI-2.6.C6 T cells function as accessory cells presenting protein antigens to long-term-cultured antigen-specific T cell lines. J Immunol 1986;136:2033–2040.

Ben-Nun A, Strauss W, Leeman SA, Cohn LE, Murre C, Duby A, et al.: An la-positive mouse T-cell clone is functional in presenting antigen to other T cells. Immunogenetics 1985;22:123–130.

Graf L, Koch N, Schirrmacher V: Expression of Ia antigens in a murine T-lymphoma variant. Mol Immunol 1985;22:1371–1377.

Gautam SC, Matriano JA, Chikkala NF, Edinger MG, Tubbs RR: L3T4 (CD4+) cells that mediate contact sensitivity to trinitrochlorobenzene express I-A determinants. Cell Immunol 1991;135:27–41.

Reske K, Mohle U, Sun D, Wekerle H: Synthesis and cell surface display of class II determinants by long-term propagated rat T line cells. Eur J Immunol 1987;17: 909–914.

Kira J, Itoyama Y, Goto I: Generation of CD4+ blastoid T cells showing marked upregulation of CD4, class I and II MHC, and IL2 receptor molecules is required for the expression of potent encephalitogenicity. Cell Immunol 1989; 123:264–275.

Bevan DJ, Chisholm PM:Co-expression of CD4 and CD8 molecules and de novo expression of MHC class II antigens on activated rat T cells. Immunol 1986;59:621–625.

Reizis B, Schramm C, Cohen IR, Mor F: Expression of major histocompatibility complex class II molecules in rat T cells. Eur J Immunol 1994;24:2796–2802.

Yu DT, McCune JM, Fu SM, Winchester RJ, Kunkel HG: Two types of la-positive T cells. Synthesis and exchange of la antigens. J Exp Med 1980;152:89s-98s.

Yu DT, Winchester RJ, Fu SM, Gibofsky A, Ko HS, Kunkel HG: Peripheral blood la-positive T cells. Increases in certain diseases and after immunization. J Exp Med 1980;151:91–100.

Evans RL, Faldetta TJ, Humphreys RE, Pratt DM, Yunis EJ, Schlossman SF: Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express la-like antigens. J Exp Med 1978; 148: 1440–1445.

Reinherz EL, Kung PC, Pesando JM, Ritz J, Goldstein G, Schlossman SF: Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression. J Exp Med 1979;150:1472–1482.

Ko HS, Fu SM, Winchester RJ, Yu DT, Kunkel HG: Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells. J Exp Med 1979;150:246–255.

Lamb JR, Skidmore BJ, Green N, Chiller JM, Feldman M: Induction of tolerance in influenza virusimmune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med 1983;157:1434.

Lamb JR, Feldmann M: Essential requirement for major histocompatibility complex recognition in T cell tolerance induction. Nature 1984;308:72.

LaSalle JM, Tolentino PJ, Freeman GJ, Nadler LM, Hafler DA: Early signaling defects in human T cells anergized by T cell presentation of autoantigen. J Exp Med 1992;176:177–186.

LaSalle JM, Toneguzzo F, Saadeh M, Golan DE, Taber R, Hafler D: T cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction: differential MHC requirements for superantigen and autoantigen. J Immunol 1993;151:649–657.

LaSalle JM, Hafler DA: T cell anergy. FASEB J 1994;8:601–608.

Celis E, Saibara T: Binding of T cell receptor to major histocompatibility complex class II peptide complexes at the single-cell level results in the induction of antigen unresponsiveness (anergy). Eur J Immunol 1992;22:3127–3134.

Satyaraj E, Rath S, Bal V: Induction of tolerance in freshly isolated alloreactive CD4+ T cells by activated T cell stimulators. Eur J Immunol 1994;24:2457–2461.

Bettens F, Frei E, Frutig K, Mauri D, Pichler WJ, Wyss-Coray T: Noncy totoxic human CD4+ T-cell clones presenting and simultaneously responding to an antigen die of apoptosis. Cell Immunol 1995;161:72–78.

Pichler WJ, Wyss-Coray T: T cells as antigen-presenting cells. Immunol Today 1994;15:312–315.

Mannie MD, Rendali SK, Arnold PY, Nardella JP, White GA: Anergy-associated T cell antigen presentation. A mechanism of infectious tolerance in experimental autoimmune encephalomyelitis. J Immunol 1996; 157: 1062–1070.

Mauri D, Wyss-Coray T, Gallati H, Pichler WJ: Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules. J Immunol 1995;155:118–127.

Lorber MI, Loken MR, Stall AM, Fitch FW: I-A antigens on cloned alloreactive murine T lymphocytes are acquired passively. J Immunol 1982;128:2798–2803.

Arnold PY, Davidian DK, Mannie MD: Antigen presentation by T cells: T cell receptor ligation promotes antigen acquisition from professional antigen-presenting cells. Eur J Immunol 1997;27: 3198–3205.

Raposo G, Nijman HW, Stoorvogel W, Leijendekker R, Harding CV, Melief CJM, et al.:B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996;183: 1161–1172.

Mannie MD, White GA, Nardella JP, Davidian DK, Arnold PY: Partial agonism elicits an enduring phase of T cell-mediated antigen presentation. Cell Immunol 1998; 186:83–93.

Mannie MD, Nardella JP, White GA, Arnold PY, Davidian DK: Class II MHC/peptide complexes on T cell antigen-presenting cells: agonistic antigen recognition inhibits subsequent antigen presentation. Cell Immunol 1998; 186:111–120.

Mannie MD: Do holes in the T-cell repertoire have a center-surround regulatory structure? A rationale for the bifurcation of the Thl and Th2 pathways of differentiation. Med Hypotheses 1997;48:261–265.

Parish CR, O’Neill ER: Dependence of the adaptive immune response on innate immunity: some questions answered but new paradoxes emerge. Immunology & Cell Biology 1997;75:523–527.

Cook SD, Rohowsky-Kochan C, Bansil S, Dowling PC: Evidence for multiple sclerosis as an infectious disease. Acta Neurol Scand Suppl 1995;161:34–42.

Kurtzke JF: Epidemiologic evidence for multiple sclerosis as an infection [published erratum appears in Clin Microbiol Rev 1994 Jan;7(1):141]. Clin Microbiol Rev 1993;6:382–427.

Gautam AM, Liblau R, Chelvanayagam G, Steinman L, Boston T: A viral peptide with limited homology to a self peptide can induce clinical signs of experimental autoimmune encephalomyelitis [in process citation]. J Immunol 1998;161:60–64.

Ewing C, Bernard CC: Insights into the aetiology and pathogenesis of multiple sclerosis. Immunol Cell Biol 1998;76:47–54.

Bhardwaj V, Kumar V, Geysen HM, Sercarz EE: Degenerate recognition of a dissimilar antigenic peptide by myelin basic proteinreactive T cells. Implications for thymic education and autoimmunity. J Immunol 1993;151:5000–5010.

Weissert R, Svenningsson A, Lobell A, de Graaf KL Andersson R, Olsson T: Molecular and genetic requirements for preferential recruitment of TCRBV8S2+ T cells in Lewis rat experimental autoimmune encephalomyelitis. J Immunol 1998; 160:681–690.

Sun D, Le J, Coleclough C: Diverse T cell receptor beta chain usage by rat encephalitogenic T cells reactive to residues 68-88 of myelin basic protein. EurJ Immunol 1993; 23:494–498.

Sun D, Shah R, Coleclough C: Repertoire of rat MBP-reactive T cells: DNA sequencing analysis further demonstrates the clonal heterogeneity of rat T cells reactive against encephalitogenic epitopes. Cell Immunol 1994; 156: 389–401.

Sun D, Hu XZ, Le J, Swanborg RH: Characterization of brain-isolated rat encephalitogenic T cell lines. Eur J Immunol 1994;24: 1359–1364.

Sun D, Coleclough C, Hu XZ: Heterogeneity of rat encephalitogenic T cells elicited by variants of the myelin basic protein (68-86) peptide. Eur J Immunol 1995;25: 1687–1692.

Gold R, Giegerich G, Hartung HP, Toyka KV: T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR beta-chain-variable-region V beta 8.2-positive T cells are not essential for induction and course of disease. Proc Natl Acad Sci USA 1995;92:5850–5854.

Johnson BD, Nardella JP, McConnell TJ, Mannie MD: Acquired resistance to experimental autoimmune encephalomyelitis is independent of V beta usage. Cell Immunol 1997;179:55–65.

Buenafe AC, Vainiene M, Celnik B, Vandenbark AA, Offner H: Analysis of V beta 8-CDR3 sequences derived from central nervous system of Lewis rats with experimental autoimmune encephalomyelitis. J Immunol 1994;153: 386–394.

Chluba J, Steeg C, Becker A, Wekerle H, Epplen JT: T cell receptor beta chain usage in myelin basic protein-specific rat T lymphocytes. Eur J Immunol 1989;19: 279–284.

Tsuchida M, Matsumoto Y, Hirahara H, Hanawa H, Tomiyama K, Abo T: Preferential distribution of V beta 8.2-positive T cells in the central nervous system of rats with myelin basic protein-induced autoimmune encephalomyelitis. Eur J Immunol 1993;23:2399–2406.

Offner H, Buenafe AC, Vainiene M, Celnik B, Weinberg AD, Gold DP, et al.: Where, when, and how to detect biased expression of disease-relevant V beta genes in rats with experimental autoimmune encephalomyelitis. J Immunol 1993;151:506–517.

Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S: Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice [see comments]. Cell 1993;75:274–282.

Horak I: Immunodeficiency in IL2-knockout mice. Clin Immunol Immunopathol 1995;76:S172–173.

Elson CO, Sartor RB, Tennyson GS, Riddell RH: Experimental models of inflammatory bowel disease. Gastroenterology 1995; 109:1344–1367.

Tsubata R, Tsubata T, Hiai H, Shinkura R, Matsumura R, Sumida T, et al.: Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: a spontaneous model for Sjogren“s syndrome. Eur J Immunol 1996; 26:2742–2748.